Correction: Prior chemotherapy deteriorates T-cell quality for CAR T-cell therapy in B-cell non-Hodgkin’s lymphoma

Correction: Prior chemotherapy deteriorates T-cell quality for CAR T-cell therapy in B-cell non-Hodgkin’s lymphoma

Saved in:

Bibliographic Details
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2025-07-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/13/7/e010709corr1.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prior chemotherapy deteriorates T-cell quality for CAR T-cell therapy in B-cell non-Hodgkin’s lymphoma
by: Annette Künkele, et al.
Published: (2025-04-01)

CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA
by: Ugo Testa, et al.
Published: (2023-10-01)

Differential diagnosis of non-Hodgkin's B-cell lymphomas
by: A. M. Kovrigina, et al.
Published: (2022-11-01)

Genetic alterations in B-cell non-Hodgkin's lymphoma
by: Magić Zvonko, et al.
Published: (2005-01-01)

Safety and efficacy of bridging radiation therapy prior to CD19 CAR T for non-Hodgkin lymphoma: a systematic review and meta-analysis
by: Mohammad Alhomoud, et al.
Published: (2025-07-01)

Role of high-dose chemotherapy with hemopoietic stem cell transplantation in patients with non-Hodgkin's lymphomas
by: V. V. Ptushkin, et al.
Published: (2022-11-01)

Bromodomain proteins as potential therapeutic targets for B-cell non-Hodgkin lymphoma
by: Dan Zou, et al.
Published: (2024-11-01)

CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS
by: Ugo Testa, et al.
Published: (2024-01-01)

SARS-CoV-2-Induced Remission of Chemotherapy Resistance B-Cell Non-Hodgkin Lymphoma: A Case Report
by: Yan Xiao, et al.
Published: (2024-11-01)

Lymphocyte/monocyte to lactate dehydrogenase ratio prior to lymphodepletion impact the outcomes of patients with diffused large B cell lymphoma undergoing CAR-T cell therapy
by: Na Li, et al.
Published: (2025-03-01)

Rituximab in pediatric B-cell Non-Hodgkin Lymphoma: Clinical outcomes and prognostic implications
by: Şefika Akyol, et al.
Published: (2025-03-01)

B-cell non-Hodgkin's lymphoma in the patient with chronic hepatitis C and mixed cryoglobulinemia
by: V. S. Adonyeva, et al.
Published: (2015-03-01)

Prognostic Impact Of Baseline Immunologic Profile In Aggressive B-cell Non-Hodgkin’s Lymphomas
by: Safaa M. Ramadan
Published: (2021-02-01)

Treatment of B-cells non-Hodgkin lymphomas with combined immunochemotherapy: ability to treatment optimization
by: N. V. Smirnova, et al.
Published: (2015-12-01)

INVESTIGATION OF DICER1 AND BAFF GENE MUTATIONS IN B-CELL NON-HODGKIN LYMPHOMA
by: Nurcan Çırak, et al.
Published: (2024-02-01)

Serum concentrations of per- and polyfluorinated substances and risk of B-cell non-Hodgkin lymphoma
by: Jongeun Rhee, et al.
Published: (2024-10-01)

Post-therapy B regulatory cells might early predict relapse in Hodgkin lymphoma
by: Valentina Giudice, et al.
Published: (2022-04-01)

CD19‐targeting chimeric antigen receptor T‐cell therapy is safe and effective for intra‐cardiac B cell non‐Hodgkin lymphoma
by: Daniel H. Chen, et al.
Published: (2024-12-01)

CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphoma
by: Alejandro Luna, et al.
Published: (2025-04-01)

Prognostic relevance of bone marrow immune cell fractions in newly diagnosed B-cell non-Hodgkin lymphoma patients
by: Luciana Valvano, et al.
Published: (2025-12-01)

Pathologic Rupture of the Spleen in Mantle-Cell-Type Non-Hodgkin’s Lymphoma
by: Christopher B. Tan, et al.
Published: (2012-01-01)

Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomas
by: Gohar S. Manzar, et al.
Published: (2025-01-01)

COEXISTENCE OF RENAL CELL CARCINOMA AND HODGKIN' S LYMPHOMA
by: Gokhan Sargin, et al.
Published: (2014-08-01)

OCCURRENCE OF SEQUENTIAL MULTIPLE MYELOMA FOLLOWING B-CELL NON-HODGKIN LYMPHOMA: A CASE REPORT
by: DPM Almeida, et al.
Published: (2024-10-01)

Diffuse large B-cell type of the primary non-Hodgkin´s lymphoma of the liver: A diagnostic problem
by: Basarić Dragan, et al.
Published: (2025-01-01)

Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma
by: Wei Liu, et al.
Published: (2024-04-01)

Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphoma
by: Evgenii Shumilov, et al.
Published: (2025-08-01)

Breaking Age Barriers: The Benefits of CAR T-Cell Therapies in Treating Large B-Cell Lymphoma in Older Patients
by: Frank Stenner, et al.
Published: (2023-12-01)

Treatment of non-Hodgkin lymphoma with point-of-care manufactured CAR T cells: a dual institution, phase 1 trialResearch in context
by: Armin Ghobadi, et al.
Published: (2025-03-01)

Nodular Lymphocyte Predominant Hodgkin Lymphoma versus T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: A Diagnostic Challenge
by: Anton V. Rets, et al.
Published: (2014-01-01)

Early Epcoritamab Administration Revives CAR‐T Cells in Relapsed/Refractory B‐Cell Lymphomas
by: Kensuke Yanashima, et al.
Published: (2025-06-01)

Synchronous clear cell renal cell carcinoma and classic Hodgkin lymphoma
by: Phuoc Christie‐Nguyen, et al.
Published: (2025-05-01)

Maximizing the Benefit of CAR T-Cell Therapy in Lymphoma and Multiple Myeloma
by: Federico Simonetta
Published: (2022-10-01)

CAR-T CELL THERAPY IN LYMPHOMAS: EXPANSİON OF INDICATIONS AND NEW APPROACHES
by: Ayfer Gedük
Published: (2024-12-01)

Prognostic significance of immune reconstitution following CD19 CAR T‐cell therapy for relapsed/refractory B‐cell lymphoma
by: Sophia Stock, et al.
Published: (2025-01-01)

Radiomic features of PET/CT imaging of large B cell lymphoma lesions predicts CAR T cell therapy efficacy
by: Yoganand Balagurunathan, et al.
Published: (2024-11-01)

Outcomes with loncastuximab tesirine following CAR T-cell therapy in patients with relapsed or refractory diffuse large B-cell lymphoma
by: Narendranath Epperla, et al.
Published: (2024-11-01)

Intrasinusoidal Hodgkin Lymphoma; A Mimic of Anaplastic Large Cell Lymphoma
by: John R. Krause, et al.
Published: (2021-01-01)

Targeting CD30L in B-cell non-Hodgkin lymphoma: novel peptide conjugates and their therapeutic potential
by: Chaowen Shi, et al.
Published: (2025-07-01)

Primary Breast Lymphoma in a Young Female: Non-Hodgkin’s Diffuse Large B-Cell Lymphoma in the Presence of Intact Breast Prostheses
by: Ahmad Al-Bitar, et al.
Published: (2025-02-01)